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Abstract 
 
Background 
Our bones are remodelled repeatedly throughout life. New and “healthy” bone tissue replaces the 
old one. It has been shown that the bone degrading cells, the osteoclasts, prefer old and fatigued 
bone. The young bone mineral, i.e. calcium apatite, is less crystalline than the mature one. Is it 
possible that the osteoclasts distinguish between relatively old and new bone via its mineral 
crystallinity? 
 
Methodology/Principal Findings 
Acid phosphatase is an enzyme abundantly expressed by the osteoclasts during resorption and 
therefore used as a marker of the cells’ activity. This study explores whether its enzymatic activity 
would be decreased in the presence of biomimetically prepared noncrystalline calcium phosphate 
and nanocrystalline bone-like calcium apatite. The results showed that both biomimetic samples 
decreased significantly the enzyme activity while commercially available calcium phosphate 
samples (hydroxyapatite and brushite) did not. Consistent with our hypothesis the noncrystalline 
calcium phosphate had the greater inhibition effect.  
 
Conclusions/Significance 
The results showed that both biomimetic samples decreased significantly the enzyme activity while 
commercially available calcium phosphate samples (hydroxyapatite and brushite) did not. 
Consistent with our hypothesis the noncrystalline calcium phosphate had the greater inhibition 
effect.  
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Introduction 
 
Bone tissue is remodelled throughout our entire life. The old and fatigued bone is resorbed by 
specialized cells called osteoclasts. New bone is then formed by another type of cells, the 
osteoblasts. The resorption itself consists of two parallel processes. The first one is the dissolution 
of the inorganic part of the bone, the mineral calcium apatite. The second one is the degradation of 
the organic, mainly collagenous, matrix by specific proteins and intracellular mechanisms.  
 
Acid phosphatase (AcPho) is an osteoclast-produced enzyme, which is involved in the bone 
resorption process [1-3]. As a member of the acid phosphatase family this enzyme dephosphorylates 
proteins [4]. It is secreted by the human osteoclasts as a tartrate-resistant acid phosphatase type 5b. 
In this form it is also involved in the generation of reactive oxygen species (ROS) used for the 
intracellular degradation of collagen fragments [5]. Nevertheless, the role of this enzyme, that is 
largely expressed during resorption and which is therefore used as a marker of the osteoclast 
activity, is still not fully understood [3, 6, 7]. It is known, however, that most of the noncollagenous 
proteins specific to bone mineralization are active only in the phosphorylated state [8]. For instance, 
it was reported that, once dephosphorylated, bone sialoprotein and osteopontin can no longer 
promote the attachment of osteoclasts to the bone surface [9].  
 
Bone mineral matures with time and also develops microcracks [10]. There is a growing body of 
evidence that from a mineralogical perspective young and newly formed bone mineral is generally 
disordered [11-17], if not fully amorphous [18], whereas old bone mineral is more crystalline, but 
still in nanometer dimensions [19-21]. It has been experimentally shown that osteoclasts prefer to 
degrade old bone [22, 23]. Do bone cells recognize the type of bone, i.e. young or old, via its 
mineral crystallinity?  
 
In this study we examined this question assuming that acid phosphatase activity (as a marker of 
bone resorption) should be influenced by the degree of crystallinity of the bone mineral calcium 
apatite. Our hypothesis was that enzymatic activity, i.e. the enzyme role in the degradation process, 
should be diminished in the presence of young disordered bone mineral. Therefore, we evaluated 
the change of the enzyme activity (EA) in the presence of biomimetically prepared noncrystalline 
calcium phosphate and nanosized apatite. These materials were to some extent analogous in terms 
of crystallinity, chemical composition, surface area, etc. to the new and the old bone, respectively. 
Consistent with our hypothesis both samples decrease the enzymatic activity with the noncrystalline 
calcium phosphate manifesting the stronger inhibition effect. 
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Experimental 
 
Preparation of Materials 
Noncrystalline or amorphous calcium phosphate (ACP) and nanocrystalline calcium apatite (CAp) 
were synthesized in simulated body fluid (SBF). SBF is a polyelectrolyte solution mimicking the 
composition of the human plasma [24] at physiological temperature (37 C). The amorphous 
calcium phosphate was also used as a precursor for the production of the nanocrystalline apatite. 
The latter was achieved via maturation of the ACP in SBF for 24 h. For detailed description see Ref. 
[25]. 
 
The preparation method used in this study enables the production of biomimetic noncrystalline 
calcium phosphate and bone-like nanocrystalline apatite. Both products are characterized by large 
surface area (ca. 200 m
2
/g, checked by means of N2 adsorption) and carbonate content similar to 
that of the bone (ca. 5 wt%, calculated from the integral peak areas of the υ3 carbonate stretching 
region in the FTIR spectra). The CAp contains very few or no hydroxyl groups in its structure (at 
least detectable via Vacuum-FTIR spectroscopy, i.e. after removal of the residual H2O), which is 
believed to be an important feature of bone apatite [26]. The samples are bone-resembling in terms 
of their concentrations of biogenic ions such as Mg
2+
, Na
+
, and K
+
 present in SBF [25].  
 
The standards used in this study were commercially available hydroxyapatite (Ca10(PO4)6(OH)2, 
HA) and dicalcium phosphate dihydrate (CaHPO4.2H2O, DCPD, mineral name: brushite). Both 
salts were purchased from Merck. 
 
Instrumental Analysis 
X-Ray Diffraction analyses were performed using a Bruker D8 advanced diffractometer. The data 
obtained were used to determine the crystallite size with TOPAS V.3 software (the size was 
calculated from the peak width, based on the Scherrer equation) and to compare the crystallinity of 
the samples. The phases were identified as well with FTIR by means of a Nicolet Avatar 360 
spectrometer and applying the KBr pellet technique. Further analyses (SEM, surface area 
measurements, etc) of the biomimetic materials (ACP and CAp) are reported elsewhere [25].   
 
Enzyme Assay 
Acid phosphatase from wheat germ (EC 3.1.3.2.), 0.4 U/mg activity, was purchased from Sigma. 
The substrate of the enzymatic reaction was a freshly prepared 25 mM solution of 4-
nitrophenylphosphate (Fluka) in phosphate buffer (pH 5.0). The reaction was stopped with the 
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addition of 1M Na2CO3 (Merck). All assays were performed with deionized water and in sterile 
capped plastic tubes at 37°C. 
 
The enzyme was mixed at a concentration of 100 μg/ml with 5 mg calcium phosphate in phosphate 
buffer (pH 5). The total volume was 5 ml. A series of the above mixtures were incubated for 15 
minutes in a water bath with gentle agitation. At 15 min the substrate (25 mM solution of 4-
nitrophenylphosphate) was added, and the reaction was stopped after 3, 5, 9, 15, 20, and 30 minutes 
with 200 µL 1M Na2CO3. Finally, the absorbance of the product p-nitrophenolate was read at 405 
nm. The sample/enzyme ratio was 20:1 to reflect natural conditions as much as possible [4].  
 
We tested additionally whether the addition of the substrate 4-nitrophenylphosphate at time point 0 
of the interaction between the calcium phosphate samples and the enzyme rather than in the 15
th
 
minute leads to a difference in the final enzyme activity. No significant statistical difference was 
found between the two enzyme assays (p = 0.369, two-way ANOVA). It should be noted that we 
chose to measure the enzyme activity at this buffered pH rather than in the simulated body fluid. 
The reasons are that bone resorption is accomplished at pH 5.0 [1, 2], and approximately this pH is 
the optimum for the AcPho activity [27, 28]. Although, at such an acidic pH some calcium 
phosphate dissolution occurs, it is reasonable to presume that for the short time periods of the 
enzyme assay the effect is negligible [29].  
 
Additional experiments were performed in SBF (pH = 7.4) as follows. Samples of all the studied 
calcium phosphate materials (1 mg/L in SBF) were added to 4.0 mL enzyme solution. Aliquots (200 
μL) were taken at 0, 5, 10, 20, and 30 min and mixed with 1.0 mL acetate buffer, containing 50 μL 
25 mM 4-nitrophenylphosphate. After 15 min incubation at 37 ºC, 500 µL 1M sodium carbonate 
was added to stop the reaction. The absorbance was read at 405 nm. 
 
Protein Adsorption 
The change of the enzyme concentration with time in the presence of the studied calcium phosphate 
materials was determined directly by spectrophotometry at 562 nm. A standard enzyme solution 
served as a control.  
 
Statistical Analysis 
The statistical analyses were performed by means of SPSS v.13.0. Analysis of variance (ANOVA) 
was used to evaluate the statistical significance of the data and the Tukey Post-hoc test to assess the 
variations of the enzymatic activity over time. Differences at p > 0.05 were considered statistically 
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not significant for a sample size n = 6. 
 
 
Results 
 
XRD and FTIR Evaluation 
The XRD diffractograms of the studied materials are shown in Figure 1. The HA and CAp spectra 
(Fig. 1, a and b, respectively) were comparable to some extent since these materials have similar, 
but not identical crystallinity and crystallite size. Using the 002 reflections the evaluated crystallite 
sizes were about 7.73 nm for CAp and about 11.4 nm for HA. Thus the materials are nanosized 
calcium apatites. It should be noted that both materials contain carbonate ions, which cause crystal 
strain that in turn affects the peak width, i.e. the calculation of the crystallite size derived from the 
Scherrer equation. Therefore, it is reasonable to suppose that the actual size of these samples is 
bigger than the one calculated, especially for the CAp [30]. The greatest crystallinity of the HA is 
confirmed by the FTIR analysis (see below).  
 
The ACP (Fig. 1, diffractogram c) did not show distinct apatite diffraction peaks, and was thus 
considered disordered, if not fully amorphous, material. In fact, the exact degree of 
“amorphousness” of the young bone mineral is not known with certainty [18, 31, 32]. Therefore, a 
broad spectrum of non- or extremely low crystalline calcium phosphates could be referred as “bone-
like amorphous calcium phosphate”. The ACP particle size could not be determined via XRD. 
 
The DCPD diffractogram (ICDD file 02-0085) manifested a well-crystallized material (Fig. 1, d). 
Its crystallite size is greater than 1 micrometer. 
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Figure 1. XRD sprectra of the samples. HA and CAp (a and b) are characteristic of nanocrystalline 
calcium apatite. HA is more crystalline than CAp. ACP (c) lacks distinct peaks and thus is generally 
referred to as amorphous or noncrystalline material. In contrast, the brushite (diffractogram d) 
displays very well crystallized material with crystallite size larger than 1 micrometer.  
 
 
 
The FTIR examination of the materials confirmed the XRD conclusions (Fig. 2). ACP lacked a 
resolved peak in the υ4 phosphate vibrational region above 530-630 cm
-1 
(Fig. 2, a). This is typical 
for a disordered calcium phosphate phase [12, 13, 25, 33-35]. The comparison of the spectra of CAp 
and HA (Fig. 2, b and c, respectively) showed higher crystallinity of the commercially available HA 
as indicated by the greater splitting in the υ4 phosphate vibrational region above 530-630 cm
-1 
in the 
HA spectrum. CAp had higher carbonate content than HA according to the relative intensity of the 
peaks at about 1450 and 873 cm
–1
. The DCPD spectrum (Fig. 2, d) was characteristic for this 
calcium phosphate and confirmed its relatively high crystallinity. 
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Figure 2. FTIR evaluation of the samples. ACP spectrum (a) manifests noncrystalline calcium 
phosphate, which typically lacks resolved bands in the υ4 phosphate vibrational region about 530-
630 cm-1. The higher the crystallinity the greater the splitting in this region. This is well revealed in 
spectra b and c belonging to CAp and HA, respectively. According to the FTIR analysis, HA is the 
more crystalline sample, which is consistent with the XRD data. DCPD spectrum (d) shows well-
defined splitting of the phosphate bands in all regions further confirming its greater crystallinity. In 
(a), (b), and (c) the peaks about 1491 cm-1, 1430 cm-1 and 873 cm-1 are due to carbonate 
substitution. Such substitution is generally found in bone mineral. The bands about 3400 cm-1 and 
1640 cm-1 originate from bound water and/or hydroxyl ions in the apatite lattice. 
 
 
Both ACP and CAp decrease the enzyme activity, but the ACP effect is stronger  
The effects of ACP and CAp on the AcPho activity are shown in Figure 3. Both materials decreased 
the AcPho activity, with the ACP being the stronger inhibitor. The disordered calcium phosphate 
phase, i.e. the ACP inhibition of the enzyme activity was 9.4% bigger than that of CAp in the 30
th
 
minute (p<0.001). This result is consistent with our initial hypothesis.  
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It should be noted that, in general, before the fifth minute the measurements (in all studied samples) 
were not very well duplicated. The enzyme activity difference in the presence of ACP at the 3
rd
 and 
5
th
 minute was not statistically significant (p = 0.19).   
 
 
 
Figure 3. Changes in acid phosphatase enzyme activity in presence of ACP (White columns) and 
CAp (Grey columns). Error bars represent standard error of the mean [44]. Both samples decrease 
the activity of the enzyme (P < 0.001 for CAp and p = 0.001 for ACP) after the fifth minute, 
however, the inhibition effect of ACP is greater (p < 0.001). Asterisk symbol denotes no statistically 
significant difference between samples (see text).  
 
 
HA and DCPD do not decrease the enzyme activity 
Surprisingly, neither brushite nor HA influenced the AcPho activity. After 5 minutes incubation of 
the samples, the mean values of the enzyme activity remained the same until the end of the assay 
(EA(DCPD) = 0.534; SD = 0.003 and EA(HA) = 0.524; SD = 0.008). This observation suggests that the 
chemical nature of the samples was not responsible for the observed EA decrease.  
 
SBF and Ca
2+
 ions do not decrease the AcPho activity 
To test whether the biogenic ions (Na
+
, K
+
, Mg
2+
, Cl
-
, CO

3
2
) present in ACP and CAp were 
responsible for the observed phenomena, the experiment was performed in SBF. If true, the 
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simulated body fluid itself would lower the activity. However, the results obtained in SBF with or 
without samples kept the trend of those in phosphate buffer. The SBF pH of 7.4 did not have 
significant influence on the enzyme activity (data not shown).  
 
It was also hypothesized that enzyme activity could be decreased by calcium ions released from the 
samples during the assay. This idea is highly unlikely [27, 36], but needs experimental repudiation, 
since ACP has both the greater solubility and the stronger inhibition effect on the EA compared to 
CAp. However, No correlation was found between the calcium concentrations in either SBF or 
phosphate buffer and the AcPho activity (data not shown). 
  
The enzyme activity decrease is not due to protein adsorption 
We tested next whether a protein adsorption process caused the observed trends. The results are 
shown in Table 1. They indicated surprisingly that there was no enzyme adsorption by any of the 
studied materials. Thus, we must rule out the hypothesis that adsorption is responsible for the 
inhibition of the acid phosphatase enzyme activity in the presence of bone-like mineral. 
 
 
Table 1. Adsorption of acid phosphatase in the presence of the studied samples.  
Substance Absorbance @ 562 nm [mean value  SD] 
Control 5 min 15 min 30 min 
ACP 1.295  0.001 1.297  0.003 1.295  0.002 1.307  0.003 
CAp 1.218  0.001 1.217  0.000 1.225  0.000 1.227  0.003 
DCPD 1.143  0.003 1.147  0.003 1.144  0.002 1.148  0.002 
HA 1.292  0.002 1.292  0.003 1.295  0.002 1.295  0.001 
The data is reported as a mean value of four replicates with their standard deviations 
(SD). Some time points are omitted from the Table since there is no statistical 
significant difference with the ones shown.  
 
 
Discussion 
 
This study illustrates that inorganic materials can interact specifically with an enzyme, changing its 
enzymatic activity. An intriguing hypothesis can be proposed. If the results are confirmed under 
more native conditions, this will show that particular inorganic material-biomolecule interaction can 
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command cell behaviour. Briefly, we speculate that osteoclast resorption activity, which is greater in 
the case of the old and more crystalline bone, is somehow regulated via the inhibition of the acid 
phosphatase enzyme. The latter protein is strongly expressed in vivo during resorption and is 
therefore used as a marker of the osteoclastic activity. However the exact role(s) of the enzyme in 
the degradation process is still unknown [3]. 
 
What causes the observed inhibition of the enzyme activity in the presence of bone-like minerals, 
but not in the presence of other calcium phosphates compounds? Why does the noncrystalline 
biomimetic precursor show greater inhibition effect than the bone-like nanocrystalline apatite? 
 
As reported here, it is highly unlikely that these findings can be ascribed to the chemical nature of 
the samples or adsorption. Thus, we believe that some kind of surface phenomenon is driving the 
observed trends. One possibility is that the surface charge of amorphous calcium phosphate is 
positive [37], while that of calcium apatite is negative. The greater the crystallinity of the latter, the 
greater its negative surface charge [38]. However, to the best of our knowledge, the isoelectric point 
(pI) of wheat germ AcPho is not exactly defined since the enzyme is constituted by several 
isozymes with pI values ranging from about 4.0 to 7.5 [39, 40]. Thus, it is impossible to define the 
AcPho surface charge in phosphate buffer (pH = 5) and to judge with certainty whether the 
particles’ electric charge is responsible for the observed phenomenon.  
 
There are other differences between the studied materials, which should be taken into consideration, 
such as the following: ACP and CAp have larger surface areas than HA and DCPD (ACP has the 
largest of all); CAp does not contain hydroxyl ions in its crystal lattice in contrast to HA [25]; some 
transformation, i.e. crystallisation, occurs with the ACP sample during the time of the enzyme 
activity assay [41, 42]; both ACP and CAp have high carbonate content (5-7 wt%) similar to bone 
mineral, whereas HA is almost carbonate free (Fig. 2, c); DCPD has a different type of crystal 
lattice than HA and CAp.  
 
The difference between the crystallite size of the HA and Cap should also be taken into account. 
The biological response is usually very sensitive to the calcium apatites’ size (see e.g. [43]). This 
could provide an explanation as to why HA did not influence enzyme activity, while CAp did. 
Further investigation of this hypothesis is needed. 
 
Hopefully, some of the above considerations can help find the explanation of the observed 
phenomenon in the future. It should be kept in mind as well that the human osteoclasts’ AcPho is 
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tartrate resistant and contains two iron ions (II and III) [4]. The wheat germ enzyme used here is not 
tartrate resistant and does not contain Fe ions as we confirmed by means of atomic absorption 
spectroscopy. 
 
To resume, this study indicates the possibility that bone mineral itself controls osteoclast acid 
phosphatase activity by means of its crystallinity and in turn probably cell behaviour as well. As 
evidence we found that both noncrystalline calcium phosphate and nanocrystaline apatite inhibit 
enzyme activity, with the greater effect manifested by the amorphous polymorph. 
 
Acknowledgements 
The author greatly appreciates the help he was generously given by K. Gavazov and D. Raytcheva. 
The acid phosphatase used in this study was a gift from prof. G.S. Georgiev and the enzyme assays 
were performed with the assistance of his former students V. Atanasov and M. Ninov.  
 
References 
1. Vaananen HK, Liu YK, Lehenkari P, Uemara T: How do osteoclasts resorb bone? Mater Sci Eng C 1998, 
6:205-209. 
2. Vaananen HK, Zhao H, Mulari M, Halleen JM: The cell biology of osteoclast function. J Cell Sci 2000, 
113:377-381. 
3. Janckila A, Yam L: Biology and Clinical Significance of Tartrate-Resistant Acid Phosphatases: New 
Perspectives on an Old Enzyme. Calcif Tiss Int 2009, 85:465-483. 
4. Bull H, Murray PG, Thomas D, Fraser AM, Nelson PN: Acid phosphatases. J Clin Pathol Molec Pathol 
2002, 55:65-72. 
5. Halleen JM, Raisanen S, Salo JJ, Reddy SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, 
Vaananen HK: Intracellular fragmentation of bone resorption products by reactive oxygen species generated 
by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 1999, 274:22907-22910. 
6. Hayman AR: Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. 
Autoimmunity 2008, 41:218-223. 
7. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Vaananen HK: Tartrate-resistant acid phosphatase 
5b (TRACP 5b) as a marker of bone resorption. Clin Lab 2006, 52:499-509. 
8. George A, Veis A: Phosphorylated Proteins and Control over Apatite Nucleation, Crystal Growth, and 
Inhibition. Chem Rev 2008, 108:4670-4693. 
9. Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G: Dephosphorylation of osteopontin and 
bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in 
vitro. J Biol Chem 1994, 269:14853-14856. 
10. Taylor D, Hazenberg JG, Lee TC: Living with cracks: Damage and repair in human bone. Nat Mater 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.3
65
8.
2 
: P
os
te
d 
9 
No
v 
20
10
 13 
2007, 6:263-268. 
11. Olszta MJ, Cheng XG, Jee SS, Kumar R, Kim YY, Kaufman MJ, Douglas EP, Gower LB: Bone structure 
and formation: A new perspective. Mater Sci Eng R-Rep 2007, 58:77-116. 
12. Mahamid J, Sharir A, Addadi L, Weiner S: Amorphous calcium phosphate is a major component of the 
forming fin bones of zebrafish: Indications for an amorphous precursor phase. Proc Nat Acad Sci USA 2008, 
105:12748-12753. 
13. Termine JD, Posner AS: Infrared Analysis of Rat Bone - Age Dependency of Amorphous and Crystalline 
Mineral Fractions. Science 1966, 153:1523-1525. 
14. Crane NJ, Popescu V, Morris MD, Steenhuis P, Ignelzi MA: Raman spectroscopic evidence for 
octacalcium phosphate and other transient mineral species deposited during intramembranous mineralization. 
Bone 2006, 39:434-442. 
15. Gajjeraman S, Narayanan K, Hao JJ, Qin CL, George A: Matrix macromolecules in hard tissues control 
the nucleation and hierarchical assembly of hydroxyapatite. J Biol Chem 2007, 282:1193-1204. 
16. Wu LNY, Sauer GR, Genge BR, Valhmu WB, Wuthier RE: Effects of analogues of inorganic phosphate 
and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly 
growing chickens. J Inorg Biochem 2003, 94:221-235. 
17. Tao J, Pan H, Zeng Y, Xu X, Tang R: Roles of amorphous calcium phosphate and biological additives in 
the assembly of hydroxyapatite nanoparticles. J Phys Chem B 2007, 111:13410-13418  
18. Mahamid J, Aichmayer B, Shimoni E, Ziblat R, Li CH, Siegel S, Paris O, Fratzl P, Weiner S, Addadi L: 
Mapping amorphous calcium phosphate transformation into crystalline mineral from the cell to the bone in 
zebrafish fin rays. Proc Nat Acad Sci USA 2010, 107:6316-6321. 
19. Bigi A, Cojazzi G, Panzavolta S, Ripamonti A, Roveri N, Romanello M, Suarez KN, Moro L: Chemical 
and structural characterization of the mineral phase from cortical and trabecular bone. J Inorg Biochem 1997, 
68:45-51. 
20. Dorozhkin SV, Epple M: Biological and medical significance of calcium phosphates. Angew Chem Int Ed 
2002, 41:3130-3146. 
21. Peters F, Schwarz K, Epple M: The structure of bone studied with synchrotron X-ray diffraction, X-ray 
absorption spectroscopy and thermal analysis. Thermochim Acta 2000, 361:131-138. 
22. Henriksen K, Leeming DJ, Byrjalsen I, Nielsen RH, Sorensen MG, Dziegiel MH, Martin TJ, Christiansen 
C, Qvist P, Karsdal MA: Osteoclasts prefer aged bone. Osteopor Int 2007, 18:751-759. 
23. Karsdal MA, Byrjalsen I, Leeming DJ, Sorensen M, Nielsen R, Christiansen C, Henriksen K, Qvist P: 
Old bones support osteoclastogenesis superior to that of young bone, resulting in preferential resorption of 
old bone. Osteopor Int 2006, 17:S134-S134. 
24. Tas AC: Synthesis of biomimetic Ca-hydroxyapatite powders at 37 degrees C in synthetic body fluids. 
Biomaterials 2000, 21:1429-1438. 
25. Pekounov Ya, Petrov OE: Bone resembling apatite by amorphous-to-crystalline transition driven self-
organisation. J Mater Sci Mater Med 2008, 19:753-759. 
26. Pasteris JD, Wopenka B, Freeman JJ, Rogers K, Valsami-Jones E, van der Houwen JAM, Silva MJ: Lack 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.3
65
8.
2 
: P
os
te
d 
9 
No
v 
20
10
 14 
of OH in nanocrystalline apatite as a function of degree of atomic order: implications for bone and 
biomaterials. Biomaterials 2004, 25:229-238. 
27. Joyce BK, Grisolia S: Purification and prpperties of a nonspecific acid phosphatase from wheat germ. J 
Biol Chem 1960, 235:2278-2281. 
28. Kawarasaki Y, Nakano H, Yamane T: Purification and some properties of wheat germ acid phosphatases. 
Plant Sci 1996, 119:67-77. 
29. Onuma K, Ito A: Cluster growth model for hydroxyapatite. Chem Mater 1998, 10:3346-3351. 
30. Kuhn L, Grynpas M, Rey C, Wu Y, Ackerman J, Glimcher M: A Comparison of the Physical and 
Chemical Differences Between Cancellous and Cortical Bovine Bone Mineral at Two Ages. Calcif Tiss Int 
2008, 83:146-154. 
31. Grynpas MD: Transient precursor strategy or very small biological apatite crystals? Bone 2007, 41:162-
164. 
32. Weiner S: Transient precursor strategy in mineral formation of bone. Bone 2006, 39:431-433. 
33. Gadaleta SJ, Paschalis EP, Betts F, Mendelsohn R, Boskey AL: Fourier transform infrared spectroscopy 
of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: New correlations 
between X-ray diffraction and infrared data. Calcif Tiss Int 1996, 58:9-16. 
34. Li YB, Wiliana T, Tam KC: Synthesis of amorphous calcium phosphate using various types of 
cyclodextrins. Mater Res Bull 2007, 42:820-827. 
35. Somrani S, Rey C, Jemal M: Thermal evolution of amorphous tricalcium phosphate. J Mater Chem 2003, 
13:888-892. 
36. Tso SC, Chen YR: Isolation and characterization of a group III isozyme of acid phosphatase from rice 
plants. Bot Bull Acad Sin 1997, 38:245-250. 
37. Ofir PBY, Govrin-Lippman R, Garti N, Furedi-Milhofer H: The influence of polyelectrolytes on the 
formation and phase transformation of amorphous calcium phosphate. Cryst Growth Des 2004, 4:177-183. 
38. Kim HM, Himeno T, Kokubo T, Nakamura T: Process and kinetics of bonelike apatite formation on 
sintered hydroxyapatite in a simulated body fluid. Biomaterials 2005, 26:4366-4373. 
39. Hooley R: Gibberellic acid controls specific acid pshosphatase isozymes in aleurone cells and protoplasts 
of Avena Fatua L. Planta 1984, 161:355-360. 
40. Akiyama T, Yamamoto S: Immunochemical differences in acid phosphatase isozymes from wheat germ. 
Agric Biol Chem 1986, 50:437-440. 
41. Boskey AL, Posner AS: Conversion of Amorphous Calcium Phosphate to Microcrystalline 
Hydroxyapatite - pH-Dependent, Solution-Mediated, Solid-Solid Conversion. J Phys Chem 1973, 77:2313-
2317. 
42. Blumenthal NC, Holmes JM, Posner AS: Effect of Preparation Conditions on Properties and 
Transformation of Amorphous Calcium Phosphate. Mater Res Bull 1972, 7:1181-1190. 
43. Yuan Y, Liu C, Qian J, Wang J, Zhang Y: Size-mediated cytotoxicity and apoptosis of hydroxyapatite 
nanoparticles in human hepatoma HepG2 cells. Biomaterials, 31:730-740. 
44. Cumming G, Fidler F, Vaux DL: Error bars in experimental biology. J Cell Biol 2007, 177:7-11 
N
at
ur
e 
Pr
ec
ed
in
gs
 : 
hd
l:1
01
01
/n
pr
e.
20
10
.3
65
8.
2 
: P
os
te
d 
9 
No
v 
20
10
